CW Advisors LLC Takes Position in Henry Schein, Inc. $HSIC

Key Points

• CW Advisors LLC has acquired 5,750 shares of Henry Schein, Inc. (NASDAQ: HSIC) valued at approximately $398,000 during the 1st quarter of 2023.
• Several institutional investors, including Capital Fund Management S.A. and Wellington Management Group LLP, have recently increased their positions in HSIC, reflecting a strong institutional interest with ownership at 96.62%.
• Based on recent research reports, Henry Schein's average price target is $76.67, with ratings ranging from "Buy" to "Hold" from different analysts.

CW Advisors LLC purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 5,750 shares of the company's stock, valued at approximately $398,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Capital Fund Management S.A. purchased a new position in Henry Schein in the 1st quarter valued at approximately $2,182,000. Fuller & Thaler Asset Management Inc. boosted its position in Henry Schein by 9.7% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 52,868 shares of the company's stock valued at $3,621,000 after buying an additional 4,679 shares during the period. Quantbot Technologies LP purchased a new position in Henry Schein in the 1st quarter valued at approximately $2,035,000. Wellington Management Group LLP raised its holdings in shares of Henry Schein by 15.9% in the 1st quarter. Wellington Management Group LLP now owns 7,996 shares of the company's stock valued at $548,000 after purchasing an additional 1,094 shares in the last quarter. Finally, Prospector Partners LLC acquired a new stake in shares of Henry Schein in the 1st quarter valued at $7,737,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC traded up $0.55 on Monday, reaching $69.58. The company's stock had a trading volume of 1,021,767 shares, compared to its average volume of 2,089,105. The stock's 50-day moving average is $70.35 and its two-hundred day moving average is $69.98. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The stock has a market capitalization of $8.44 billion, a P/E ratio of 22.45, a PEG ratio of 2.30 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. During the same period in the previous year, the company posted $1.23 earnings per share. Henry Schein's quarterly revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. UBS Group reduced their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a report on Wednesday, August 6th. Wells Fargo & Company reduced their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a report on Monday, July 14th. Evercore ISI upgraded shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target on the stock in a research note on Tuesday, August 26th. Finally, Wall Street Zen upgraded shares of Henry Schein from a "hold" rating to a "buy" rating in a research note on Saturday. Five investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.